RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: chronic myeloid leukemia
Accession: DOID:8552
browse the term
Definition: A myeloid leukemia that is characterized by over production of white blood cells. (DO)
Synonyms: exact_synonym: CML; CML - chronic myelogenous leukemia; Chronic Myeloid Leukemias; EFO:0000339 ; PH1-positive myeloid leukemia; PH1-positive myeloid leukemias; Ph1-positive myelogenous leukemia; Ph1-positive myelogenous leukemias; Philadelphia-positive myeloid leukemia; chronic granulocytic leukaemia; chronic granulocytic leukemia; chronic granulocytic leukemias; chronic myelocytic leukemia; chronic myelocytic leukemias; chronic myelogenous leukaemia; chronic myelogenous leukemia; chronic myelogenous leukemia, BCR-ABL positive; chronic myelogenous leukemias; chronic myeloid leukaemia
narrow_synonym: CHRONIC MYELOID LEUKEMIA, RESISTANT TO IMATINIB; Philadelphia chromosome-positive leukemia, resistant to imatinib
broad_synonym: ABL1-RELATED CONDITION; ABL1-RELATED DISORDER
primary_id: MESH:D015464
alt_id: MIM:608232
xref: EFO:0000339 ; EFO:0000340 ; GARD:6105 ; ICD9CM:205.1 ; ICDO:9863/3; NCI:C3174 ; ORDO:521
For additional species annotation, visit the
Alliance of Genome Resources .
G
ABCB1
ATP-binding cassette, sub-family B (MDR/TAP), member 1
susceptibility treatment
ISO
DNA:SNP, haplotype: :3435C>T (human) DNA:SNPs: :1236T>C,2677G>A(human)
RGD
PMID:24581936 PMID:26250462
RGD:11081178 RGD:11081180
NCBI chr 9:93,049,955...93,146,469
G
ABCC2
ATP binding cassette subfamily C member 2
treatment
ISO
DNA:haploltype: :-24C>T, 1249G>A, 3972C>T(human)
RGD
PMID:25060527
RGD:11080961
NCBI chr14:110,955,698...111,038,898
Ensembl chr14:110,955,582...111,038,898
G
ABCG2A
ATP binding cassette subfamily G member 2A
treatment susceptibility
ISO
DNA:SNP: :421C>A(human) DNA:SNP,haplotype: :C>A421(human) DNA:haplotype:cds: p.Q141K,p.V12M,(rs2231142),(rs2725252)(human)
RGD
PMID:24123600 PMID:24581936 PMID:26250462
RGD:11081178 RGD:11081180 RGD:11081181
NCBI chr 8:130,853,414...130,945,388
Ensembl chr 8:130,775,444...130,945,393
G
ABL1
ABL proto-oncogene 1, non-receptor tyrosine kinase
susceptibility treatment
ISO
ClinVar Annotator: match by term: ABL1-related disorder | ClinVar Annotator: match by term: Leukemia, Philadelphia chromosome-positive, resistant to imatinib DNA:missense mutations: :multiple
OMIM ClinVar RGD
PMID:3021820 PMID:10988075 PMID:11423618 PMID:11569495 PMID:11853795 PMID:11861307 PMID:11964322 PMID:12130516 PMID:12399961 PMID:12623848 PMID:12663457 PMID:14559829 PMID:14745431 PMID:15194504 PMID:15256422 PMID:15381060 PMID:18615627 PMID:19466505 PMID:19652056 PMID:20367437 PMID:20512393 PMID:20537386 PMID:20697894 PMID:20963643 PMID:21481795 PMID:21505103 PMID:21562040 PMID:21762985 PMID:21872826 PMID:21895409 PMID:22306673 PMID:22772060 PMID:22870928 PMID:23289634 PMID:23355941 PMID:23540562 PMID:23676790 PMID:24236021 PMID:24456693 PMID:24728327 PMID:25157968 PMID:25686603 PMID:25741868 PMID:28492532 PMID:33783941 PMID:36063163 More...
RGD:11038807 RGD:11038814 RGD:1598673
NCBI chr 1:270,761,641...270,906,708
Ensembl chr 1:270,761,668...270,906,708
G
ACE
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1
ISO
RGD
PMID:19761684
RGD:11039056
NCBI chr12:15,394,487...15,414,609
Ensembl chr12:15,394,487...15,414,703
G
AGT
angiotensinogen
ISO
RGD
PMID:19761684
RGD:11039056
NCBI chr14:59,643,030...59,656,835
Ensembl chr14:59,643,292...59,656,833
G
AKT1
AKT serine/threonine kinase 1
ISO
protein:increased phosphorylation:blood
RGD
PMID:17900686
RGD:13674160
G
ALOX5
arachidonate 5-lipoxygenase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19503090 PMID:19823023
NCBI chr14:90,859,209...90,907,084
Ensembl chr14:90,859,019...90,907,090
G
ARNTL
aryl hydrocarbon receptor nuclear translocator like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16999817
NCBI chr 2:45,895,637...46,025,174
Ensembl chr 2:45,895,289...45,988,570
G
BCL2L1
BCL2 like 1
ISO
RGD
PMID:20728382
RGD:11353850
NCBI chr17:35,366,139...35,415,798
Ensembl chr17:35,366,143...35,414,694
G
BCR
BCR activator of RhoGEF and GTPase
treatment susceptibility disease_progression
ISO
BCR/ABL fusion DNA:gene fusion DNA:translocations:cds: DNA:methylation: :
OMIM RGD
PMID:2683759 PMID:3101769 PMID:7683349 PMID:12613514
RGD:11038776 RGD:11038783 RGD:1600510 RGD:41404631
NCBI chr14:49,208,662...49,322,109
Ensembl chr14:49,208,762...49,322,103
G
BIRC5
baculoviral IAP repeat containing 5
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16254145
NCBI chr12:3,747,276...3,755,214
Ensembl chr12:3,747,279...3,755,215
G
BRAF
B-Raf proto-oncogene, serine/threonine kinase
ISO
ClinVar Annotator: match by term: Chronic myelogenous leukemia
ClinVar
PMID:24033266 PMID:24446311 PMID:25157968 PMID:26619011
NCBI chr18:8,957,963...9,132,558
Ensembl chr18:8,957,991...9,132,553
G
CA9
carbonic anhydrase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17157168
NCBI chr 1:236,393,727...236,400,994
Ensembl chr 1:236,394,306...236,400,822
G
CASP6
caspase 6
treatment
ISO
human cells in mouse model
RGD
PMID:31952546
RGD:151667904
NCBI chr 8:112,519,450...112,534,315
Ensembl chr 8:112,520,629...112,537,045
G
CD36
CD36 molecule
ISO
protein:increased expression:platelet, cell surface
RGD
PMID:8555064
RGD:11041099
NCBI chr 9:99,685,748...99,782,296
Ensembl chr 9:99,605,181...99,782,105
G
CD40
CD40 molecule
ISO
protein:increased expression:peripheral blood, dendritic cell (human)
RGD
PMID:16527350
RGD:11520794
NCBI chr17:48,286,116...48,298,188
Ensembl chr17:48,286,029...48,298,528
G
CDKN1B
cyclin dependent kinase inhibitor 1B
ISO
Protein:increased expression:Blood,common myeloid progenitor, CD34-positive
RGD
PMID:20200561
RGD:13673878
NCBI chr 5:59,731,224...59,735,831
Ensembl chr 5:59,731,206...59,735,831
G
CDKN2A
cyclin dependent kinase inhibitor 2A
treatment
ISO
RGD
PMID:16533530
RGD:11251777
NCBI chr 1:200,774,496...200,799,149
Ensembl chr 1:200,792,469...200,798,854
G
CHORDC1
cysteine and histidine rich domain containing 1
ISO
OMIM:608232
MouseDO
NCBI chr 9:23,187,770...23,208,592
Ensembl chr 9:23,181,850...23,208,683
G
CRKL
CRK like proto-oncogene, adaptor protein
ISO
protein:increased phosphorylation:blood
RGD
PMID:17900686
RGD:13674160
NCBI chr14:50,528,950...50,558,664
Ensembl chr14:50,528,955...50,558,662
G
CRY1
cryptochrome circadian regulator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16999817
NCBI chr 5:13,275,265...13,429,566
Ensembl chr 5:13,275,545...13,364,593
G
CRY2
cryptochrome circadian regulator 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16999817
NCBI chr 2:16,587,101...16,620,380
Ensembl chr 2:16,587,109...16,620,385
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
treatment
ISO
DNA:polymorphism:cds:4889A>G(p.I462V)(human)
RGD
PMID:26464823
RGD:11352729
NCBI chr 7:58,802,887...58,809,155
Ensembl chr 7:58,802,887...58,809,775
G
CYP3A22
cytochrome P450 family 3 subfamily A member 22
treatment susceptibility
ISO
DNA:SNP:: (rs776746) (human) DNA:polymorphism:intron :6986A>G (human)
RGD
PMID:19584153 PMID:21039054
RGD:11353798 RGD:11353810
NCBI chr 3:6,617,256...6,665,179
Ensembl chr 3:6,615,343...6,822,817
G
DNMT1
DNA methyltransferase 1
disease_progression
ISO
RGD
PMID:11222358
RGD:9588667
NCBI chr 2:68,981,564...69,040,364
Ensembl chr 2:68,981,566...69,029,844
G
DNMT3A
DNA methyltransferase 3 alpha
disease_progression
ISO
RGD
PMID:11222358
RGD:9588667
NCBI chr 3:113,501,972...113,609,148
Ensembl chr 3:113,528,926...113,603,087
G
DNMT3B
DNA methyltransferase 3 beta
disease_progression
ISO
RGD
PMID:11222358
RGD:9588667
NCBI chr17:36,345,715...36,386,076
Ensembl chr17:36,345,816...36,386,072
G
E2F1
E2F transcription factor 1
ISO
mRNA:increased expression:blood
RGD
PMID:26460262
RGD:13674165
NCBI chr17:37,178,587...37,190,118
Ensembl chr17:37,178,599...37,189,883
G
ERCC2
ERCC excision repair 2, TFIIH core complex helicase subunit
ISO
DNA:polymorphism: :p.K751Q (human) DNA:polymorphism: :p.K751Q (rs13181) (human)
RGD
PMID:24955348 PMID:25311495
RGD:11060463 RGD:11252188
NCBI chr 6:51,734,318...51,757,508
Ensembl chr 6:51,734,320...51,757,553
G
EZH2
enhancer of zeste 2 polycomb repressive complex 2 subunit
ISO
mRNA:increased expression:bone marrow mononuclear cells (human)
RGD
PMID:27070757
RGD:13782088
NCBI chr 9:109,384,976...109,450,943
Ensembl chr 9:109,385,015...109,450,941
G
FAS
Fas cell surface death receptor
susceptibility
ISO
DNA:polymorphisms, haplotype:promoter: -670 G>A, -1377 G>A (human)
RGD
PMID:26563376
RGD:11049146
NCBI chr14:100,927,305...100,954,781
Ensembl chr14:100,927,089...100,956,716
G
FASLG
Fas ligand
susceptibility
ISO
DNA:polymorphism:promoter: -844 T>C(human)
RGD
PMID:26563376
RGD:11049146
NCBI chr 9:115,068,314...115,075,147
Ensembl chr 9:115,068,090...115,076,464
G
FGFR3
fibroblast growth factor receptor 3
ISO
mRNA:increased expression:peripheral blood (human)
RGD
PMID:14562121
RGD:36947884
NCBI chr 8:879,151...894,968
Ensembl chr 8:879,159...894,964
G
GAB2
GRB2 associated binding protein 2
disease_progression
ISO
protein:increased expression:bone marrow
RGD
PMID:22858987
RGD:13699433
NCBI chr 9:12,663,658...12,851,423
Ensembl chr 9:12,663,657...12,851,342
G
GPX1
glutathione peroxidase 1
no_association
ISO
DNA:polymorphism: :p.P198L (human)
RGD
PMID:25436036
RGD:11352762
NCBI chr13:31,916,269...31,917,337
Ensembl chr13:31,916,246...31,917,433
G
HES1
hes family bHLH transcription factor 1
ISO
rat gene in a mouse model
RGD
PMID:19861684
RGD:9685380
NCBI chr13:131,135,970...131,137,865
Ensembl chr13:131,135,725...131,138,237
G
HMMR
hyaluronan mediated motility receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17157168
NCBI chr16:60,290,684...60,332,411
Ensembl chr16:60,290,001...60,331,936
G
HMOX1
heme oxygenase 1
ISO
RGD
PMID:22139798
RGD:10755566
G
HSPA5
heat shock protein family A (Hsp70) member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23777986
NCBI chr 1:265,930,044...265,934,959
Ensembl chr 1:265,930,045...265,934,894
G
IL10
interleukin 10
treatment
ISO
RGD
PMID:20305143
RGD:11049154
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
G
IL1RN
interleukin 1 receptor antagonist
severity
ISO
RGD
PMID:7949186
RGD:10450889
G
INSL6
insulin like 6
ISO
ClinVar Annotator: match by term: Chronic myelogenous leukemia
ClinVar
PMID:15781101 PMID:15793561 PMID:15837627 PMID:15858187 PMID:15920007 PMID:16081687 PMID:16247455 PMID:16293597 PMID:16325696 PMID:16603627 PMID:16707754 PMID:16709929 PMID:16762626 PMID:17989398 PMID:18256599 PMID:18394554 PMID:19036091 PMID:19074595 PMID:19287384 PMID:19293426 PMID:20339092 PMID:20631743 PMID:20703299 PMID:21120162 PMID:21689158 PMID:22041374 PMID:22397670 PMID:22422826 PMID:22571758 PMID:22818858 PMID:22829971 PMID:23115274 PMID:23535062 PMID:24404189 PMID:24986690 PMID:25043017 PMID:25157968 PMID:25671252 PMID:25741868 PMID:28492532 PMID:32581362 More...
NCBI chr 1:216,792,785...216,820,197
Ensembl chr 1:216,792,787...216,823,479
G
JAK2
Janus kinase 2
ISO
ClinVar Annotator: match by term: Chronic myelogenous leukemia
ClinVar
PMID:15781101 PMID:15793561 PMID:15837627 PMID:15858187 PMID:15920007 PMID:16081687 PMID:16247455 PMID:16293597 PMID:16325696 PMID:16603627 PMID:16707754 PMID:16709929 PMID:16762626 PMID:17989398 PMID:18256599 PMID:18394554 PMID:19036091 PMID:19074595 PMID:19287384 PMID:19293426 PMID:20339092 PMID:20631743 PMID:20703299 PMID:21120162 PMID:21689158 PMID:22041374 PMID:22397670 PMID:22422826 PMID:22571758 PMID:22818858 PMID:22829971 PMID:23115274 PMID:23535062 PMID:24404189 PMID:24986690 PMID:25043017 PMID:25157968 PMID:25671252 PMID:25741868 PMID:28492532 PMID:32581362 More...
NCBI chr 1:216,849,744...217,002,310
Ensembl chr 1:216,848,689...217,002,148
G
KRAS
KRAS proto-oncogene, GTPase
ISO
ClinVar Annotator: match by term: Chronic myelogenous leukemia
ClinVar
PMID:2278970 PMID:3122217 PMID:8439212 PMID:15696205 PMID:16361624 PMID:16434492 PMID:16618717 PMID:17332249 PMID:17384584 PMID:17704260 PMID:18316791 PMID:19018267 PMID:19047918 PMID:19075190 PMID:19114683 PMID:19255327 PMID:19349489 PMID:19358724 PMID:19679400 PMID:19773371 PMID:19881948 PMID:20609353 PMID:20921462 PMID:20921465 PMID:20949621 PMID:21044336 PMID:21169357 PMID:21228335 PMID:21398618 PMID:21975775 PMID:22235099 PMID:22407852 PMID:22683711 PMID:22897852 PMID:23096712 PMID:23406027 PMID:24033266 PMID:24138715 PMID:25157968 PMID:25741868 PMID:26242988 PMID:26372703 PMID:28492532 PMID:29298116 PMID:31891627 More...
NCBI chr 5:48,508,774...48,546,260
Ensembl chr 5:48,508,811...48,549,358
G
LOC100739508
glutathione S-transferase P-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20843134
NCBI chr 2:5,005,498...5,009,247
G
LOC110258578
interleukin-1 beta-like
severity
ISO
RGD
PMID:7949186
RGD:10450889
G
MAPK14
mitogen-activated protein kinase 14
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16818652
NCBI chr 7:31,791,398...31,861,544
Ensembl chr 7:31,790,877...31,862,031
G
MDM2
MDM2 proto-oncogene
onset
ISO
DNA:SNP:promoter:rs2279744(human)
RGD
PMID:23818300
RGD:13703044
NCBI chr 5:33,105,717...33,137,602
Ensembl chr 5:33,105,759...33,137,739
G
MIR150-1
microRNA mir-150-1
ISO
miRNA:decreased expression:leukocytes
RGD
PMID:21501493
RGD:13782140
NCBI chr 6:54,580,912...54,580,988
Ensembl chr 6:54,580,912...54,580,988
G
MTHFR
methylenetetrahydrofolate reductase
ISO
DNA:SNPs: :677C>T, 1298A>C(human)
RGD
PMID:17156840
RGD:10449408
NCBI chr 6:71,863,637...71,882,118
Ensembl chr 6:71,863,637...71,881,820
G
NCSTN
nicastrin
ISO
OMIM:608232
MouseDO
NCBI chr 4:90,121,209...90,142,934
Ensembl chr 4:90,119,002...90,142,890
G
NQO1
NAD(P)H quinone dehydrogenase 1
ISO
DNA:SNP: :609C>T (human)
RGD
PMID:16235982
RGD:10769357
NCBI chr 6:17,292,962...17,302,593
Ensembl chr 6:17,292,770...17,302,590
G
NRAS
NRAS proto-oncogene, GTPase
ISO
ClinVar Annotator: match by term: Chronic myelogenous leukemia
ClinVar
PMID:2278970 PMID:2674680 PMID:3122217 PMID:8120410 PMID:12460918 PMID:16273091 PMID:16291983 PMID:16434492 PMID:17699718 PMID:18390968 PMID:18948947 PMID:19075190 PMID:19657110 PMID:20130576 PMID:20179705 PMID:20619739 PMID:20736745 PMID:21305640 PMID:21729679 PMID:21829508 PMID:22407852 PMID:23134356 PMID:23334668 PMID:23414587 PMID:23515407 PMID:23614898 PMID:25157968 PMID:25741868 PMID:26619011 PMID:28594414 PMID:30417923 PMID:32888943 More...
NCBI chr 4:105,845,913...105,853,769
Ensembl chr 4:105,845,872...105,858,227
G
PECAM1
platelet and endothelial cell adhesion molecule 1
ISO
protein:increased expression:serum (human)
RGD
PMID:16521495
RGD:11552593
NCBI chr12:14,667,643...14,723,296
Ensembl chr12:14,649,044...14,723,293
G
PER1
period circadian regulator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16999817
NCBI chr12:53,361,863...53,376,723
Ensembl chr12:53,361,889...53,374,248
G
PER2
period circadian regulator 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16999817
NCBI chr15:137,793,419...137,837,854
Ensembl chr15:137,793,422...137,837,070
G
PER3
period circadian regulator 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16999817
NCBI chr 6:68,487,634...68,548,718
G
PRAME
PRAME nuclear receptor transcriptional regulator
ISO
mRNA:increased expression:mononuclear cell (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17157168 PMID:20838376
RGD:11535035
NCBI chr14:48,901,097...48,906,855
Ensembl chr14:48,899,343...48,911,231
G
PRTN3
proteinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17157168
NCBI chr 2:77,520,314...77,526,303
Ensembl chr 2:77,520,314...77,523,563
G
SF3B1
splicing factor 3b subunit 1
ISO
ClinVar Annotator: match by term: Chronic myelogenous leukemia
ClinVar
PMID:23395771 PMID:25741868
NCBI chr15:101,274,968...101,338,018
Ensembl chr15:101,276,851...101,299,105
G
SH2B3
SH2B adaptor protein 3
ISO
OMIM:608232
MouseDO
NCBI chr14:32,623,286...32,664,606
Ensembl chr14:32,623,286...32,664,606
G
SIPA1
signal-induced proliferation-associated 1
ISO
OMIM:608232
MouseDO
NCBI chr 2:6,606,613...6,618,556
Ensembl chr 2:6,606,626...6,618,566
G
SMAD4
SMAD family member 4
ISO
mRNA:decreased expression:blood
RGD
PMID:29951173
RGD:13782079
NCBI chr 1:100,521,843...100,633,501
Ensembl chr 1:100,589,850...100,628,029
G
SRSF1
serine and arginine rich splicing factor 1
ISO
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:23228155
RGD:11038774
NCBI chr12:34,278,363...34,282,164
Ensembl chr12:34,272,956...34,282,162
G
STAT5A
signal transducer and activator of transcription 5A
treatment disease_progression
ISO
human cells in mouse model mRNA:increased expression:PBMC (human)
RGD
PMID:16522816 PMID:31952546
RGD:151667903 RGD:151667904
NCBI chr12:20,474,221...20,498,785
Ensembl chr12:20,474,227...20,499,138
G
TERT
telomerase reverse transcriptase
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15068898 PMID:17157168
RGD:11038663
NCBI chr16:79,258,591...79,276,421
Ensembl chr16:79,258,591...79,276,421
G
TGFB1
transforming growth factor beta 1
ISO
protein:increased expression:serum
RGD
PMID:29951173
RGD:13782079
NCBI chr 6:49,332,169...49,348,642
Ensembl chr 6:49,332,173...49,349,046
G
USP15
ubiquitin specific peptidase 15
ISO
mRNA, protein:decreased expression:PBMC (human)
RGD
PMID:31952546
RGD:151667904
NCBI chr 5:26,964,380...27,082,549
Ensembl chr 5:26,964,553...27,097,444
G
VEGFA
vascular endothelial growth factor A
susceptibility
ISO
DNA:SNP,haplotype: :(rs6999470),(rs833061)(human)
RGD
PMID:19141860
RGD:13432135
NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366
G
WT1
WT1 transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17157168
NCBI chr 2:28,411,467...28,456,007
Ensembl chr 2:28,411,803...28,455,997
G
XRCC1
X-ray repair cross complementing 1
susceptibility
ISO
DNA:SNP:cds :p.R194W(human)
RGD
PMID:26250462
RGD:11081180
NCBI chr 6:50,403,691...50,425,730
Ensembl chr 6:50,403,689...50,425,729
G
AICDA
activation induced cytidine deaminase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21570118
NCBI chr 5:62,777,236...62,787,342
Ensembl chr 5:62,777,352...62,787,369
G
BCR
BCR activator of RhoGEF and GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21570118
NCBI chr14:49,208,662...49,322,109
Ensembl chr14:49,208,762...49,322,103
G
ESR2
estrogen receptor 2
ISO
RGD
PMID:12740446
RGD:734951
NCBI chr 1:193,823,666...193,907,330
Ensembl chr 1:193,829,560...193,906,565
G
HMOX1
heme oxygenase 1
ISO
RGD
PMID:22139798
RGD:10755566
G
MIR150-1
microRNA mir-150-1
ISO
miRNA:decreased expression:leukocytes
RGD
PMID:21501493
RGD:13782140
NCBI chr 6:54,580,912...54,580,988
Ensembl chr 6:54,580,912...54,580,988
G
TCN2
transcobalamin 2
ISO
protein:increased expression::
RGD
PMID:1059479
RGD:11060122
NCBI chr14:47,496,245...47,515,966
Ensembl chr14:47,502,715...47,515,965
G
ABL1
ABL proto-oncogene 1, non-receptor tyrosine kinase
ISO
ClinVar Annotator: match by term: Chronic myelogenous leukemia, BCR-ABL1 positive
ClinVar
PMID:10988075 PMID:11423618 PMID:11567109 PMID:11569495 PMID:11853795 PMID:11861307 PMID:11964322 PMID:12130516 PMID:12399961 PMID:12576318 PMID:12623848 PMID:12663457 PMID:12783380 PMID:14559829 PMID:14745431 PMID:15194504 PMID:15256422 PMID:15381060 PMID:15510211 PMID:17008892 PMID:17114651 PMID:17189410 PMID:18223278 PMID:18354488 PMID:18615627 PMID:18757400 PMID:18828913 PMID:19164531 PMID:19264234 PMID:19466505 PMID:19557636 PMID:19652056 PMID:19768693 PMID:19811824 PMID:20010464 PMID:20367437 PMID:20512393 PMID:20537386 PMID:20557306 PMID:20607847 PMID:20697894 PMID:20702476 PMID:20963643 PMID:21221851 PMID:21489624 PMID:21505103 PMID:21509757 PMID:21562040 PMID:21605905 PMID:21762985 PMID:21872826 PMID:21888027 PMID:21895409 PMID:22210874 PMID:22306673 PMID:22772060 PMID:22870928 PMID:22912393 PMID:23355941 PMID:23540562 PMID:23575252 PMID:23676790 PMID:24109527 PMID:24236021 PMID:24456693 PMID:25152116 PMID:25157968 PMID:25686603 PMID:25741868 PMID:28492532 PMID:31775759 PMID:36063163 More...
NCBI chr 1:270,761,641...270,906,708
Ensembl chr 1:270,761,668...270,906,708
G
BCR
BCR activator of RhoGEF and GTPase
ISO
ClinVar Annotator: match by term: Chronic myelogenous leukemia, BCR-ABL1 positive
ClinVar
PMID:25741868 PMID:28492532
NCBI chr14:49,208,662...49,322,109
Ensembl chr14:49,208,762...49,322,103
G
BRAF
B-Raf proto-oncogene, serine/threonine kinase
ISO
ClinVar Annotator: match by term: Chronic myelogenous leukemia, BCR-ABL1 positive
ClinVar
PMID:24033266 PMID:24446311 PMID:25157968 PMID:26619011
NCBI chr18:8,957,963...9,132,558
Ensembl chr18:8,957,991...9,132,553
G
CSF3R
colony stimulating factor 3 receptor
ISO
ClinVar Annotator: match by term: Chronic myelogenous leukemia, BCR-ABL1 positive
ClinVar
PMID:23604229 PMID:23634996 PMID:23656643 PMID:24081659 PMID:24403076 PMID:24614839 PMID:24854193 PMID:25491280 PMID:25741868 PMID:25932451 PMID:26875968 PMID:27148573 PMID:27581359 PMID:28209919 PMID:28219221 PMID:28492532 PMID:28762112 PMID:30967555 PMID:31697825 More...
NCBI chr 6:92,550,159...92,565,798
Ensembl chr 6:92,550,161...92,565,477
G
IKZF1
IKAROS family zinc finger 1
ISO
ClinVar Annotator: match by term: Chronic myelogenous leukemia, BCR-ABL1 positive
ClinVar
NCBI chr 9:136,372,202...136,464,942
Ensembl chr 9:136,372,725...136,464,940
G
INSL6
insulin like 6
ISO
ClinVar Annotator: match by term: Chronic myelogenous leukemia, BCR-ABL1 positive
ClinVar
PMID:15781101 PMID:15793561 PMID:15837627 PMID:15858187 PMID:15920007 PMID:16081687 PMID:16247455 PMID:16293597 PMID:16325696 PMID:16603627 PMID:16707754 PMID:16709929 PMID:16762626 PMID:17989398 PMID:18256599 PMID:18394554 PMID:19036091 PMID:19074595 PMID:19287384 PMID:19293426 PMID:20339092 PMID:20631743 PMID:20703299 PMID:21120162 PMID:21689158 PMID:22041374 PMID:22397670 PMID:22422826 PMID:22571758 PMID:22818858 PMID:22829971 PMID:23115274 PMID:23535062 PMID:24404189 PMID:24986690 PMID:25043017 PMID:25157968 PMID:25671252 PMID:25741868 PMID:28492532 PMID:32581362 More...
NCBI chr 1:216,792,785...216,820,197
Ensembl chr 1:216,792,787...216,823,479
G
JAK2
Janus kinase 2
ISO
ClinVar Annotator: match by term: Chronic myelogenous leukemia, BCR-ABL1 positive
ClinVar
PMID:15781101 PMID:15793561 PMID:15837627 PMID:15858187 PMID:15920007 PMID:16081687 PMID:16247455 PMID:16293597 PMID:16325696 PMID:16603627 PMID:16707754 PMID:16709929 PMID:16762626 PMID:17989398 PMID:18256599 PMID:18394554 PMID:19036091 PMID:19074595 PMID:19287384 PMID:19293426 PMID:20339092 PMID:20631743 PMID:20703299 PMID:21120162 PMID:21689158 PMID:22041374 PMID:22397670 PMID:22422826 PMID:22571758 PMID:22818858 PMID:22829971 PMID:23115274 PMID:23535062 PMID:24404189 PMID:24986690 PMID:25043017 PMID:25157968 PMID:25671252 PMID:25741868 PMID:28492532 PMID:32581362 More...
NCBI chr 1:216,849,744...217,002,310
Ensembl chr 1:216,848,689...217,002,148
G
KIT
KIT proto-oncogene, receptor tyrosine kinase
ISO
ClinVar Annotator: match by term: Chronic myelogenous leukemia, BCR-ABL1 positive
ClinVar
PMID:16307017 PMID:22703879 PMID:24728327 PMID:25741868 PMID:28492532 PMID:31775759 More...
NCBI chr 8:41,402,334...41,492,306
Ensembl chr 8:41,402,043...41,493,734
G
KRAS
KRAS proto-oncogene, GTPase
ISO
ClinVar Annotator: match by term: Chronic myelogenous leukemia, BCR-ABL1 positive
ClinVar
PMID:2278970 PMID:3122217 PMID:8439212 PMID:15696205 PMID:16361624 PMID:16434492 PMID:16618717 PMID:17332249 PMID:17384584 PMID:17704260 PMID:18316791 PMID:19018267 PMID:19047918 PMID:19075190 PMID:19114683 PMID:19255327 PMID:19349489 PMID:19358724 PMID:19679400 PMID:19773371 PMID:19881948 PMID:20609353 PMID:20921462 PMID:20921465 PMID:20949621 PMID:21044336 PMID:21169357 PMID:21228335 PMID:21398618 PMID:21975775 PMID:22235099 PMID:22407852 PMID:22683711 PMID:22897852 PMID:23096712 PMID:23406027 PMID:24033266 PMID:24138715 PMID:25157968 PMID:25741868 PMID:26242988 PMID:26372703 PMID:28492532 PMID:29298116 PMID:31891627 More...
NCBI chr 5:48,508,774...48,546,260
Ensembl chr 5:48,508,811...48,549,358
G
NRAS
NRAS proto-oncogene, GTPase
ISO
ClinVar Annotator: match by term: Chronic myelogenous leukemia, BCR-ABL1 positive
ClinVar
PMID:2278970 PMID:2674680 PMID:3122217 PMID:8120410 PMID:12460918 PMID:16273091 PMID:16291983 PMID:16434492 PMID:17699718 PMID:18390968 PMID:18948947 PMID:19075190 PMID:19657110 PMID:20130576 PMID:20179705 PMID:20619739 PMID:20736745 PMID:21305640 PMID:21729679 PMID:21829508 PMID:22407852 PMID:23134356 PMID:23334668 PMID:23414587 PMID:23515407 PMID:23614898 PMID:25157968 PMID:25741868 PMID:26619011 PMID:28594414 PMID:30417923 PMID:32888943 More...
NCBI chr 4:105,845,913...105,853,769
Ensembl chr 4:105,845,872...105,858,227
G
SETBP1
SET binding protein 1
ISO
ClinVar Annotator: match by term: Chronic myelogenous leukemia, BCR-ABL1 positive
ClinVar
PMID:18398855 PMID:18414213 PMID:20436468 PMID:21371013 PMID:23222956 PMID:23400866 PMID:25082129 PMID:25741868 PMID:28492532 More...
NCBI chr 1:94,295,332...94,666,560
Ensembl chr 1:94,295,851...94,663,017
G
SF3B1
splicing factor 3b subunit 1
ISO
ClinVar Annotator: match by term: Chronic myelogenous leukemia, BCR-ABL1 positive
ClinVar
PMID:23395771 PMID:25741868
NCBI chr15:101,274,968...101,338,018
Ensembl chr15:101,276,851...101,299,105
G
IRF8
interferon regulatory factor 8
ISO
OMIM:600080
MouseDO
NCBI chr 6:3,041,617...3,060,685
Ensembl chr 6:3,041,645...3,097,406
G
BMI1
BMI1 proto-oncogene, polycomb ring finger
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24571310
NCBI chr10:52,586,089...52,596,154
Ensembl chr10:52,586,509...52,596,564
G
MIR150-1
microRNA mir-150-1
ISO
miRNA:decreased expression:leukocytes
RGD
PMID:21501493
RGD:13782140
NCBI chr 6:54,580,912...54,580,988
Ensembl chr 6:54,580,912...54,580,988
G
ABL1
ABL proto-oncogene 1, non-receptor tyrosine kinase
disease_progression
ISO
DNA:hypermethylation:promoter
RGD
PMID:11559572 PMID:19344397
RGD:11038809 RGD:11038811
NCBI chr 1:270,761,641...270,906,708
Ensembl chr 1:270,761,668...270,906,708
G
BCR
BCR activator of RhoGEF and GTPase
disease_progression
ISO
RGD
PMID:19344397
RGD:11038809
NCBI chr14:49,208,662...49,322,109
Ensembl chr14:49,208,762...49,322,103
G
CYP3A22
cytochrome P450 family 3 subfamily A member 22
treatment
ISO
DNA:polymorphism:intron :6986A>G (human)
RGD
PMID:23394475
RGD:11353797
NCBI chr 3:6,617,256...6,665,179
Ensembl chr 3:6,615,343...6,822,817
G
ERCC1
ERCC excision repair 1, endonuclease non-catalytic subunit
treatment
ISO
DNA:SNP: :rs11615 (human)
RGD
PMID:22821389
RGD:11252165
NCBI chr 6:51,783,537...51,808,898
Ensembl chr 6:51,783,478...51,798,984
G
GFI1
growth factor independent 1 transcriptional repressor
disease_progression
ISO
mRNA,protein:increased expression:mononuclea cell, CD34+ cell
RGD
PMID:19887785 PMID:23411466
RGD:11040457 RGD:11040461
NCBI chr 4:124,619,887...124,629,638
Ensembl chr 4:124,621,261...124,629,638
G
GFI1B
growth factor independent 1B transcriptional repressor
ISO
mRNA:increased expression:blood:
RGD
PMID:19360458
RGD:11040460
NCBI chr 1:272,701,386...272,715,551
Ensembl chr 1:272,702,184...272,715,539
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all